Home LiteratureArticle Details
PMID: 12464660 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy.

The Journal of clinical investigation ·Vol. 110 ·No. 11 ·2002-12-00 ·Pages 1585-90

Lomas DA, Mahadeva R

Abstract

暂无摘要

MeSH Terms
Humans Liver/metabolism,pathology Macromolecular Substances Models, Molecular Protein Structure, Secondary Serine Proteinase Inhibitors/chemistry,metabolism Serpins/metabolism alpha 1-Antitrypsin/chemistry,metabolism alpha 1-Antitrypsin Deficiency/metabolism,pathology
Chemicals
Macromolecular Substances Serine Proteinase Inhibitors Serpins alpha 1-Antitrypsin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lomas David A
Respiratory Medicine Unit, Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom. dal16@cam.ac.uk
Mahadeva Ravi
References (32)
32 references, click to expand
  1. Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease.
    Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):67-72 PMID: 10618372
  2. Chemotactic activity of elastin-derived peptides.
    J Clin Invest. 1980 Oct;66(4):859-62 PMID: 6903189
  3. Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease.
    Protein Sci. 2000 Jul;9(7):1274-81 PMID: 10933492
  4. Evolving concepts in the pathogenesis of chronic obstructive pulmonary disease.
    Clin Chest Med. 2000 Dec;21(4):621-32 PMID: 11194774
  5. Prevention of polymerization of M and Z alpha1-Antitrypsin (alpha1-AT) with trimethylamine N-oxide. Implications for the treatment of alpha1-at deficiency.
    Am J Respir Cell Mol Biol. 2001 Jun;24(6):727-32 PMID: 11415938
  6. Dissecting glycoprotein quality control in the secretory pathway.
    Trends Biochem Sci. 2001 Oct;26(10):619-24 PMID: 11590015
  7. The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes.
    J Biol Chem. 2001 Nov 30;276(48):44865-72 PMID: 11577074
  8. Alpha1-antitrypsin deficiency--a model for conformational diseases.
    N Engl J Med. 2002 Jan 3;346(1):45-53 PMID: 11778003
  9. 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis.
    J Biol Chem. 2002 Mar 1;277(9):6771-4 PMID: 11773044
  10. Mutant Neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro.
    J Biol Chem. 2002 May 10;277(19):17367-73 PMID: 11880376
  11. Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema.
    Am J Respir Cell Mol Biol. 2002 Jun;26(6):723-30 PMID: 12034572
  12. Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury.
    J Clin Invest. 2002 Dec;110(11):1579-83 PMID: 12464659
  13. Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis.
    J Clin Invest. 2002 Dec;110(11):1591-7 PMID: 12464661
  14. alpha 1-antitrypsin deficiency in early childhood.
    Pediatrics. 1978 Jul;62(1):22-5 PMID: 308215
  15. Lung lavage fluid from patients with alpha 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile.
    Clin Sci (Lond). 1987 Mar;72(3):373-81 PMID: 2434283
  16. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
    J Clin Invest. 1987 Nov;80(5):1366-74 PMID: 3500183
  17. The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant.
    J Exp Med. 1988 May 1;167(5):1608-15 PMID: 3259253
  18. Soluble aggregates of the human PiZ alpha 1-antitrypsin variant are degraded within the endoplasmic reticulum by a mechanism sensitive to inhibitors of protein synthesis.
    J Biol Chem. 1992 Jan 15;267(2):1072-80 PMID: 1530934
  19. The mechanism of Z alpha 1-antitrypsin accumulation in the liver.
    Nature. 1992 Jun 18;357(6379):605-7 PMID: 1608473
  20. The molecular basis of alpha 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease.
    J Hepatol. 1993 Jul;18(3):313-21 PMID: 8228125
  21. A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency.
    Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9014-8 PMID: 8090762
  22. Mutations which impede loop/sheet polymerization enhance the secretion of human alpha 1-antitrypsin deficiency variants.
    J Biol Chem. 1995 Apr 14;270(15):8393-6 PMID: 7721731
  23. What do dysfunctional serpins tell us about molecular mobility and disease?
    Nat Struct Biol. 1995 Feb;2(2):96-113 PMID: 7749926
  24. The Z type variation of human alpha 1-antitrypsin causes a protein folding defect.
    Nat Struct Biol. 1995 May;2(5):363-7 PMID: 7664092
  25. Inhibitory conformation of the reactive loop of alpha 1-antitrypsin.
    Nat Struct Biol. 1996 Aug;3(8):676-81 PMID: 8756325
  26. Structural explanation for the deficiency of S alpha 1-antitrypsin.
    Nat Struct Biol. 1996 Nov;3(11):910-1 PMID: 8901864
  27. Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema.
    Am J Respir Cell Mol Biol. 1998 May;18(5):670-4 PMID: 9569237
  28. Inhibition of intracellular degradation increases secretion of a mutant form of alpha1-antitrypsin associated with profound deficiency.
    J Clin Invest. 1998 Jun 15;101(12):2693-701 PMID: 9637703
  29. A kinetic mechanism for the polymerization of alpha1-antitrypsin.
    J Biol Chem. 1999 Apr 2;274(14):9548-55 PMID: 10092640
  30. Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis.
    J Clin Invest. 1999 Apr;103(7):999-1006 PMID: 10194472
  31. Familial dementia caused by polymerization of mutant neuroserpin.
    Nature. 1999 Sep 23;401(6751):376-9 PMID: 10517635
  32. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency.
    Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1796-801 PMID: 10677536
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
DOI
10.1172/JCI16782
Email
dal16@cam.ac.uk
Published
2002-12-00
Pages
1585-90
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC151637
Subset
IM
External Links
PubMed source DOI: 10.1172/JCI16782 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2